
NIH funding cuts — a ‘what if?’ look back; paying more for less successful surgical outcomes; on choices, habit and health — Morning Medical Update
Key Takeaways
- A 40% NIH funding cut from 2000 could have significantly hindered drug development progress, affecting healthcare advancements.
- U.S. inpatient operative expenditures exceed $500 billion annually, with significant variations in hospital cost markups and associated morbidity.
The top news stories in medicine today.
The U.S. Department of Health and Human Services has undergone some major changes under the leadership of (HHS) Secretary. While no one knows exactly what the effects will be, reconsidering the past might indicate what could happen for drug development. A group of authors proposed a “what if” scenario to examine what might have happened over the last 25 years if the National Institutes of Health had a 40% funding cut from 2000 onward. Here’s a
In the U.S. health care system, inpatient operative expenditures cost more than $500 billion a year. In a new study of major elective operations, researchers found “significant variation” in hospital cost markup around the country. It’s true that hospitals have growing financial pressures from uninsured and underinsured patients, along with other economic factors. But “these challenges do not explain the significant variation in hospital markup” — and the greater morbidity at those hospitals. “Hospital Price Markup and Outcomes of Major Elective Operations” is an original investigation in
Do patients (and physicians) make rational choices to pursue the means to good health? Or do people fall back on the repetition of habit, for better or worse? A
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.















